Qianhong Bio-pharma(SZ:002550)2022-12-08 01:34Company Overview - The company is engaged in the pharmaceutical industry, focusing on both pharmaceutical and healthcare sectors for mergers and acquisitions [3][4] - The company has established a strategic plan to expand its market presence and product offerings [6] Mergers and Acquisitions - The company is actively pursuing mergers and acquisitions based on strategic requirements, focusing on firms with stable operations and market potential [3][4] - The company has engaged with numerous enterprises and will proceed cautiously to ensure alignment with its standards [4] Market Coverage - The company's product "Yikai" covers most provinces in China, with established markets in Beijing, Tianjin, and Jiangsu, and potential markets in Hubei, Sichuan, Chongqing, and Zhejiang [4] - The company has restructured its sales organization to enhance market penetration and support existing channels [4] Product Development - The company is exploring new applications for its products, such as "Yikai" being used for male infertility in Germany and menopausal symptoms in Japan [4] - The company has established six research directions at the "Zhonghong Research Institute," with several products in clinical testing and commercialization [7] Cost Management - The company has successfully reduced costs for "Pancreatic Kininogenase" due to lower procurement costs and improved production processes [5] - Future cost control will be supported by utilizing its wholly-owned subsidiary for raw material production [5] Strategic Planning - The company is involved in the reform of public medical institutions in Changzhou and aims to build a multi-tiered medical network [6] - Plans include expanding into high-end elderly care services and leveraging capital markets for growth [6] Talent Development - The company has implemented a talent strategy focusing on nurturing young leaders and establishing a performance evaluation system [9] - Over the past three years, seven young talents, including two PhDs and two Masters, have been promoted to the board and management [9]